menu
The globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development

Despite the fact thatbiopharmaceuticals offer significant profit margins, innovator companies areplagued by high costs of development, complex production protocols and specialprocedures and equipment for fill / finish operations. Consequently, a numberof drug manufacturers have demonstrated a preference for outsourcing fill /finish operations of such products.

 

To order this 480+page report, which features 350+ figures and 260+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

The USD 4.2 billion(by 2030) financial opportunity within the biologics fill / finish services markethas been analyzed across the following segments:

§  Types of Primary Packaging Containers

§  Ampoules

§  Cartridges

§  Syringes

§  Vials

 

§  Types of Biologics

§  Peptides / proteins

§  Antibodies

§  Vaccines

§  Cell therapies

§  Gene therapies

§  Viral products

§  Oligonucleotides

§  Others

 

§  Company Size

§  Small-sized

§  Mid-sized

§  Large / very large

 

§  Scale of Operation

§  Preclinical

§  Clinical

§  Commercial

 

§  Key Therapeutic Areas

§  Cancer

§  Infectious diseases

§  Autoimmune diseases

§  Cardiovascular diseases

§  Other indications

 

§  Key Geographical Regions

§  North America (US, Canada)

§  Europe (UK, France, Germany, Italy, Spain and rest of theEurope)

§  Asia-Pacific (Japan, China, South Korea, India andAustralia)

 

The BiologicsFill / Finish Services Market, 2019-2030.”report features thefollowing companies, which we identified to be key players in this domain:

§  Advanced BioScience Laboratories(ABL)

§  Albany Molecular Research (AMRI)

§  Biocon

§  BioPharma Solutions

§  BioReliance

§  Boehringer IngelheimBioXcellence

§  ChemPartner

§  Emergent BioSolutions

§  IDT Biologika

§  Lonza

§  LuinaBio

§  Mycenax Biotech

§  Patheon

§  Recipharm

§  Vetter Pharma

§  WuXi Biologics

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Competitive Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers inNorth America: Company Profiles

7. Biologics Fill / Finish Service Providers inEurope: Company Profiles 

8. Biologics Fill / Finish Service Providers inAsia-Pacific: Company Profiles

9. Partnerships and Collaborations

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Biologics Manufacturing and Fill / Finish:Key Performance Indicator Analysis

14. Market Sizing and Opportunity Analysis

 

15. Future Growth Opportunities

 

16. Case Study: Robotic Systems in Fill /Finish Operations

 

17. Case Study: Ready-to-Use PackagingComponents in Aseptic Fill / Finish Operations

 

18. Conclusion

 

19. Interview Transcripts

 

20. Appendix 1: Tabulated Data

 

21. Appendix 2: List of Companies andOrganizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com